الفهرس 
List of AbbreviationsOnly 14 pages are availabe for public view
 |  | from | 102 |  |  |
| | | from | 102 | | |
Abstract
In 2005, Balloon sinuplasty technology was approved for use in the United States by the Food and Drug Administration (FDA) as a minimally invasive treatment alternative for the chronic rhinosinusitis. Balloon Sinuplasty alters the sinus cavities by reshaping the bony structure, as opposed to FESS where bone is actually removed, with minimal mucosal damage, minimal intraoperative bleeding and minimal discomfort.
The procedure can be performed under local anesthesia, or conscious sedation, so it holds promises for office type sinus procedures. The balloon sinuplasty appears to be a feasible, safe and effective procedure in selected patients. It presents itself as complementary to functional endoscopic sinus surgery used in the treatment of chronic rhinosinusitis patients, who have failed antibiotic therapy, topical steroids and allergic management as demonstrated by an abnormal CT scan.
It has greater prospects in the treatment of the disease related to the frontal recess.It also has an excellent perspective in ICU febrile patient with sinusal focus and patients with high anesthetic and bleeding risks. Sinuplasty morbidity and complications are the same as with FESS; however, owing to the less invasive nature of the procedure, they are likely to be less common.
Although limited to the frontal, maxillary, and sphenoid sinuses, the technique of the procedure is achievable with appropriate training, minimal morbidity, and complications. However, its long-term value as a standalone procedure has not yet been proven.
- Balloon sinuplasty is a novel technology for otolaryngologists.
- It is a safe technique with low morbidity.
- It is shown to improve patient symptoms in data of 2 year follow up in a selected group of patients.
- It holds promises for office type sinus procedures.
- More study is needed to define its role in sinus surgery in particular patient selection and disease type best suited for this technology.